Literature DB >> 10587741

[Buprenorphine and pregnancy. Analysis of 24 cases].

M Jernite1, B Viville, B Escande, J P Brettes, J Messer.   

Abstract

BACKGROUND: Maintenance therapy of drug-addict mothers with medical and psychosocial support may reduce complications (prematurity, growth retardation, fetal distress and fetal death). Methadone has been widely used during pregnancy with beneficial effects. Buprenorphine (BUP) is used more and more and shows the same beneficial effects. PATIENTS AND
METHOD: Twenty-four pregnant women received BUP and their infants were enrolled in the study. Thirteen retrospective (GI) and 11 prospective (GII) cases were studied. In the GII, the women were treated and followed up in an interdisciplinary manner.
RESULTS: Complications in GII were less frequent than in GI: 9 vs 30% of prematurity, 9 vs 46% of fetal growth retardation and 0 vs 23% of acute fetal distress. However, the frequency of withdrawal syndrome was the same in both groups, 63 vs 69%, though improvements came more rapidly in GII.
CONCLUSION: This study shows that the use of BUP during pregnancy, combined with medical and psychosocial support, may reduce addiction complications. This support has to be maintained after the birth.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587741     DOI: 10.1016/S0929-693X(00)86300-9

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  5 in total

1.  Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.

Authors:  Isabelle Lacroix; Alain Berrebi; Daniel Garipuy; Laurent Schmitt; Yamina Hammou; Catherine Chaumerliac; Maryse Lapeyre-Mestre; Jean-Louis Montastruc; Christine Damase-Michel
Journal:  Eur J Clin Pharmacol       Date:  2011-05-03       Impact factor: 2.953

2.  Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadone.

Authors:  Nathalie Colombini; Riad Elias; Muriel Busuttil; Myriam Dubuc; Marie-Ange Einaudi; Martine Bues-Charbit
Journal:  Pharm World Sci       Date:  2007-11-16

Review 3.  Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.

Authors:  Hendrée E Jones; Sarah H Heil; Andjela Baewert; Amelia M Arria; Karol Kaltenbach; Peter R Martin; Mara G Coyle; Peter Selby; Susan M Stine; Gabriele Fischer
Journal:  Addiction       Date:  2012-11       Impact factor: 6.526

4.  Substance abuse in pregnancy: opioid substitution in a northern Ireland maternity unit.

Authors:  Sandra Mawhinney; Robin G Ashe; Joanne Lowry
Journal:  Ulster Med J       Date:  2006-09

5.  A Swedish Population-based Study of Adverse Birth Outcomes among Pregnant Women Treated with Buprenorphine or Methadone: Preliminary Findings.

Authors:  Keele E Wurst; Barbara K Zedler; Andrew R Joyce; Maciek Sasinowski; E Lenn Murrelle
Journal:  Subst Abuse       Date:  2016-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.